|
UBTF expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.168300E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.160100E-03 |
| Normal-vs-Stage2 |
6.985400E-01 |
| Normal-vs-Stage3 |
7.99760000000926E-05 |
| Normal-vs-Stage4 |
3.16560000002131E-06 |
| Stage1-vs-Stage2 |
5.694300E-02 |
| Stage1-vs-Stage3 |
1.193400E-01 |
| Stage1-vs-Stage4 |
1.004090E-02 |
| Stage2-vs-Stage3 |
8.499200E-03 |
| Stage2-vs-Stage4 |
1.500970E-03 |
| Stage3-vs-Stage4 |
3.340400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.628300E-04 |
| Normal-vs-AfricanAmerican |
8.408000E-02 |
| Normal-vs-Asian |
2.370200E-02 |
| Caucasian-vs-AfricanAmerican |
5.601600E-01 |
| Caucasian-vs-Asian |
5.814400E-01 |
| AfricanAmerican-vs-Asian |
8.729400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.338300E-03 |
| Normal-vs-Female |
9.013700E-04 |
| Male-vs-Female |
8.049400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.823430E-03 |
| Normal-vs-Age(41-60Yrs) |
5.397100E-03 |
| Normal-vs-Age(61-80Yrs) |
3.395200E-04 |
| Normal-vs-Age(81-100Yrs) |
2.247200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.156000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.966800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.493000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.119600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.175400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.099200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.44550000003019E-06 |
| Classical-VS-Follicular |
5.954600E-01 |
| Classical-VS-Other |
2.667400E-01 |
| Classical-VS-Normal |
4.798400E-03 |
| Tall-VS-Follicular |
1.903720E-03 |
| Tall-VS-Other |
6.022400E-01 |
| Tall-VS-Normal |
1.91129999604911E-08 |
| Follicular-VS-Other |
5.229400E-01 |
| Follicular-VS-Normal |
1.265570E-02 |
| Other-VS-Normal |
4.352300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.328450E-02 |
| Normal-vs-N1 |
2.58849999990041E-07 |
| N0-vs-N1 |
3.798400E-04 |
|
|
